H-纤维胶凝蛋白对功能性相关冠状动脉疾病的诊断与预后价值
本研究在1571例疑似功能性相关冠状动脉疾病(fCAD)患者中评估H-纤维胶凝蛋白(H-ficolin)的诊断与预后价值。H-ficolin在静息、负荷试验峰值及试验后2小时测量,fCAD经心肌灌注成像SPECT和冠状动脉造影判定。结果显示H-ficolin对fCAD无显著诊断价值(AUC 0.53),在总体队列中也不是事件预测因子,仅亚组分析提示在无fCAD患者中可能与非致命性心肌梗死存在关联。
要点
- H-ficolin对功能性相关冠状动脉疾病无显著诊断价值(AUC 0.53)。
- 在总体队列中H-ficolin不是心血管事件预测因子。
- 亚组分析提示无fCAD患者中H-ficolin与非致命性心肌梗死可能相关。
核心结论
- H-ficolin浓度在因fCAD接受检查的患者中既无诊断价值也无预后价值。
研究设计与样本
- 研究纳入1571例患者(32.3%为女性),fCAD通过心肌灌注成像SPECT和冠状动脉造影判定。
- H-ficolin采用夹心免疫分析法在静息、负荷试验峰值和试验后2小时测量。
- 随访5年评估心血管死亡和非致命性心肌梗死。
主要发现
- fCAD检出率为29.4%(462/1571)。
- 静息H-ficolin浓度在fCAD患者为18.6(15.3-21.8)µg/ml,无fCAD患者为17.8(15.4-21.5)µg/ml,p=0.33。
- H-ficolin诊断fCAD的AUC为0.53(95%CI 0.48-0.56)。
- 随访期间107例(6.8%)发生非致命性心肌梗死,99例(6.3%)发生心血管死亡。
- Cox回归分析中H-ficolin不是总体队列的事件预测因子;亚组分析显示无fCAD患者中H-ficolin与非致命性心肌梗死可能相关(调整HR 1.03,95%CI 1.02-1.15,p=0.005)。
临床怎么用
- H-ficolin目前不推荐用于fCAD的诊断或预后评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to test the diagnostic and prognostic ability of H-ficolin, an initiator of the lectin pathway of the complement system, for functionally relevant coronary artery disease (fCAD), and explore its determinants. METHODS: The presence of fCAD was adjudicated using myocardial perfusion imaging single-photon emission tomography and coronary angiography. H-ficolin levels were measured by a sandwich-type immunoassay at rest, peak stress-test, and 2 h after stress-test. Cardiovascular death and non-fatal myocardial infarction were assessed during 5-year follow-up. RESULTS: Among 1,571 patients (32.3 % women), fCAD was detected in 462 patients (29.4 %). H-ficolin concentration at rest was 18.6 (15.3-21.8) µg/ml in patients with fCAD versus 17.8 (15.4-21.5) µg/ml, p = 0.33, in patients without fCAD, resulting in an AUC of 0.53 (95 %CI 0.48-0.56). During follow-up, 107 patients (6.8 %) had non-fatal myocardial infarction and 99 patients (6.3 %) experienced cardiovascular death. In Cox regression analysis, H-ficolin was not a predictor of events in the overall cohort. Subgroup analysis suggested a potential link between H-ficolin and non-fatal myocardial infarction in patients without fCAD (adjusted HR 1.03, 95 % CI 1.02-1.15, p = 0.005). H-ficolin concentration showed a weak positive correlation with systolic (r = 0.069, p < 0.001) and diastolic blood pressure (r = 0.111, p < 0.001). CONCLUSION: H-ficolin concentration did not have diagnostic and/or prognostic value in patients referred for fCAD work-up.
引用
- Isayeva G, Potlukova E, Rumora K, et al. Diagnostic and prognostic value of H-ficolin for functionally relevant coronary artery disease. Clin Chim Acta. 2023. PMID: 37802208. doi:10.1016/j.cca.2023.117582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。